#USA #New York #cognitive health #Stroke Prevention #Brain Health Coalition

Launch of the International Brain Health Coalition

On October 5, 2026, the International Brain Health Coalition (IBC) was established, uniting a multidisciplinary global community to translate brain health research into equitable and practical solutions. This initiative primarily focuses on a bold project known as the 30×30×50 Brain Challenge. By 2031, the coalition aims to reduce stroke rates by 30% and increase cognitive health screenings in primary care by 50% across 30 cities worldwide.

The IBC is coordinated by the Atria Research and Global Health Institute (ARGHI) and involves various stakeholders including patients, sector leaders, and multilateral institutions like the United Nations. Its mission is not just to generate knowledge but to implement existing scientific findings through community programs and policies that directly impact individuals in their everyday environments rather than just within medical facilities.

Neurological and cardiometabolic diseases are leading causes of disability and illness globally, creating immense economic strains on families and healthcare systems. With known risk factors for stroke and dementia, the real challenge lies in operationalizing this scientific knowledge effectively. Dr. David Dodick, Chair of the IBC and Chief Science and Medical Officer at Atria Health Institute, stated, "We are currently facing immense human suffering and a tremendous burden on the global economy. We possess the scientific knowledge to prevent these conditions, but what is lacking is the infrastructure to act upon it. The IBC was instituted to bridge this gap."

Among its many partners, the IBC collaborates with UN Women, Thrive Global, Eli Lilly and Company, Bristol Myers Squibb, instilling a diverse array of expertise to enhance brain health initiatives. Dr. Khadija Rejto, Vice Chair of the IBC, emphasized the extraordinary advancements being made in understanding cardiovascular, metabolic, and endocrine interactions affecting brain health. The coalition seeks to leverage this knowledge to shape brain health discussions where they most impact individuals' lives.

The 30×30×50 Brain Challenge is set to start in two pilot cities: London, Ontario, Canada, and Oslo, Norway. In London, the coalition's primary project named “CanDo Brain Health Implementation Initiative” will involve 800 participants engaged in a scalable program focused on factors influencing cognitive decline through AI and human coaching. Meanwhile, Oslo will serve as the European launchpad of IBC, integrating advanced predictive health research at the AI-Mind research facility.

Dr. Vladimir Hachinski of the Western Institute for Neuroscience remarked, "Brain health underpins individual and societal well-being, and we have known for decades how to protect it. We have lacked a way to make this knowledge accessible to all. The IBC is the first initiative established for this very purpose."

Oslo aims to create a scalable early intervention model by integrating cognitive assessments with blood biomarker evaluations and long-term home monitoring. This innovative approach will provide insights into the factors influencing cognitive health over time and identify risks before they lead to serious neurological disorders.

The coalition’s formation is timely, with increasing awareness and research highlighting the impact of dementia—particularly affecting women, who represent nearly two-thirds of those impacted by Alzheimer’s disease. Sima Bahous, UN Under-Secretary-General, emphasized the importance of embedding gender health considerations into the coalition's goals.

The IBC stands as a trailblazer uniting neurology, cardiology, metabolic health, and behavioral sciences into a comprehensive implementation platform. The coalition is rooted in Geneva, Switzerland, as a non-profit organization with a mission to close the gap between scientific knowledge and public access.

With its ambitious vision and collaborative approach, the International Brain Health Coalition is poised to transform the landscape of brain health across the globe, making significant strides toward equitable access to care and prevention strategies that benefit all communities. As the coalition commences its initiatives, its potential impact could resonate well beyond the initial cities involved, aiming for global health improvements against neurological diseases.